The inflammation protocol — cold, red light, and PEMF for acute and chronic inflammation

Cold vs. red light: different mechanisms for different inflammation phases

Cold plunge works through vasoconstriction and local neural effects: it's fast, physically mechanical, and best matched to acute soreness where reducing immediate discomfort is the goal; its evidence for broader inflammation control is weaker than its evidence for soreness relief specifically. Red light therapy works by supporting mitochondrial function and modulating cellular signaling: it's slower-acting, best used consistently over weeks, and has at least one striking (if unreplicated) human RCT behind its systemic anti-inflammatory potential.

These aren't competing approaches: they address different phases of the inflammatory process, with different levels of evidentiary support. Cold for the first 24–48 hours of acute soreness; red light for the subacute and chronic resolution phase that follows. For athletes managing recurrent soreness or inflammation across a training season, using both at their appropriate timing produces a more complete protocol than relying on either alone, while being honest that PEMF's role here rests on plausible mechanism rather than demonstrated systemic effect.

A realistic weekly inflammation protocol

• Day 1 of acute soreness or injury: cold plunge or cryotherapy (5–10 min at 50–59°F); repeat the following morning if still acute.
• Days 2–7: red light therapy on the affected area (15 min, 1–2x/day) as the inflammatory response moves from acute to subacute.
• Ongoing weeks: maintain red light 3–5x/week; add PEMF if systemic or neurological inflammation components are present, understanding that its systemic anti-inflammatory effect is not yet demonstrated in trials.
• Any day with sauna: infrared sauna 2–3x/week as long-term systemic anti-inflammatory maintenance, not a substitute for acute-phase management.

What's evidence and what's convention

The strongest evidence in this protocol backs the narrowest claims: cold for short-term perceived soreness relief (Cochrane-reviewed), and one striking single-RCT signal for red light lowering inflammatory cytokines in people who start elevated. PEMF's inclusion here rests on in-vitro adenosine-receptor mechanism work, not on human trials showing it lowers systemic inflammatory markers in general wellness users: that question is open, not settled, and members should not be told PEMF is a proven anti-inflammatory tool. The overall sequencing (cold first for acute soreness, red light for the resolution phase, PEMF and sauna as longer-term layers) is a reasonable, mechanism-consistent structure, but it has not itself been tested as a single protocol against alternatives.